SGX Research 2

Half the STI Constituents Averaged 1.5%+ Daily Trading Ranges in 1H18

The non-weighted average 90 day volatility of the 30 STI constituents increased by a third over the first six months, rising to an annualised 22.5% at the end of June, up from 16.7% at the end of 2017. As many as 15 STI stocks averaged daily trading ranges over 1.50% in the first six months of the year, ranging from UOL Group & Wilmar’s 1.52% to Yangzijiang Shipbuilding’s 3.24%.
SGX Research 2

REITs & Stapled Trusts Average 6.7% Distribution Yield

Following strong growth of Singapore private property prices at 9.1% over the past 12M & subsequent further tightening of private property cooling measures, the 34 REITs & six Stapled Trusts maintain an average distribution yield of 6.7%.
SGX Research 1

Big Healthcare Plays A Key Market Highlight Of 1H18

Four of the five biggest weights of the SGX All Healthcare Index have gained in the 2018 YTD leading the Index to a 6% total return for the period. Top Glove Corp Bhd has been the strongest performer with a 56% total return.
SGX Research 2

Singapore’s Leading Real Estate Agency PropNex Makes Debut on SGX

PropNex, Singapore’s leading real estate brokerage, made its trading debut on SGX Mainboard today. It has four main business segments – Real Estate Brokerage, Training, Property Management and Real Estate Consultancy. Frost & Sullivan forecasts Singapore’s primary private residential transactions to grow at a CAGR of 3.8% in volume, and 6.5% in value, between 2017 and 2022.
SGX Research 2

Five STI Stocks Consistently Increased Dividends Over 5 years

Five STI stocks that have consistently increased its dividends over the past 5 years are SATS, ComfortDelGro, Jardine Matheson, Jardine Strategic and HongKong Land. These five stocks make up almost 15% of the STI weight & averaged a dividend yield of 3.0% in 2017.
SGX Research 1

SGX Healthcare Index’s Three Largest Pharma Stocks Avg 8% YTD Return

Six constituents in the SGX All Healthcare Index are categorised to the pharmaceuticals segment. The three largest and actively traded pharma stocks are Tianjin Zhongxin Pharma, Haw Par and iX Biopharma, which have a combined market capitalisation of S$5.6 billion. Tianjin Zhongxin Pharma, Haw Par, and iX Biopharma have posted total returns of +19.7%, +16.0% and -11.9% in the 2018 YTD. Note that Tianjin Zhongxin and Haw Par are also the 3rd and 5th best-performing constituents of the SGX All Healthcare Index in the YTD.
SGX Research 1

Three Largest, Best-Performing Consumer Stocks Avg 7% Return in May

In the month of May, Consumer Discretionary, which comprises a total of 95 stocks, was the best-performing sector on SGX, generating a market capitalisation-weighted average return of 3.1% during the month. The 10 largest, actively traded Consumer Discretionary stocks on SGX have a combined market capitalisation of more than S$60 billion, and have generated an average total return of 1.9% over the month.